Sterling Capital Management’s Eikon Therapeutics EIKN Stock Holding History

Sterling Capital Management’s Portfolio EIKN Stock Details EIKN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48K	Buy	+190	New	+$1.94K	﹤0.01%	2937

Other funds holding EIKN

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Sterling Capital Management's EIKN Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 190 shares worth $2.48K. The stake represents ﹤0.01% of the portfolio and ranks #2937 among its holdings.

12 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

Sterling Capital Management held 190 shares of Eikon Therapeutics worth $2.48K as of Q2 2026.
Eikon Therapeutics was a new Sterling Capital Management position in Q2 2026.
Eikon Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2937 holding.
12 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.